Bioavailability and bioeffectiveness of subcutaneous human insulin and two of its analogs-Lys(B28)Pro(B29)-human insulin and Asp(B10)Lys(B28)Pro(B29)-human insulin-assessed in a conscious pig model

Diabetes

Volumn 46, Issue 4, 1997, Pages 548-556

  Radziuk, Jerry M ^a   Davies, Jill C ^a   Pye, W Susan ^a   Shields, James E ^b   DiMarchi, Richard D ^b   Chance, Ronald E ^b  

^a UNIVERSITY OF OTTAWA   (Canada)

^b ELI LILLY AND COMPANY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HUMAN INSULIN; INSULIN DERIVATIVE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG EFFICACY; FEMALE; GLUCONEOGENESIS; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; INSULIN BLOOD LEVEL; LIVER METABOLISM; METABOLIC CLEARANCE RATE; NONHUMAN; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION; SWINE;

EID: 0030898508     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diab.46.4.548     Document Type: Article

References (52)

1. Hildebrandt P, Sejrsen P, Nielsen SL, Birch K, Sestoft L: Diffusion and polymerization determine the insulin absorption from subcutaneous tissue in diabetic patients. Scand J Clin Lab Invest 45:685-690, 1985
2. B28) in healthy subjects. Diabetes Care 14:1057-1065, 1991
3. DiMarchi RD, Mayer JP, Fan L, Brems DN, Frank BH, Green LK, Hoffmann JA, Howey CD, Long HB, Shaw WN, Shields JE, Slieker LJ, Su KSE, Sundell KL, Chance RE: Synthesis of a fast-acting insulin based on structural homology with insulin-like growth factor I. In Peptides: Chemistry and Biology. Smith JA, Rivier JE, Eds. Leiden, ESCOM, 1992, p. 26-28
4. Long HB, Baker JC, Belagaje RM, DiMarchi RD, Frank BH, Green LK, Hoffmann JA, Muth WL, Pekar AH, Reams SG, Shaw WN, Shields JE, Slieker LJ, Su KSE, Sundell KL, Chance RE: Human insulin analogs with rapid onset and short duration of action. In Peptides: Chemistry and Biology, Smith JA, Rivier JE, Eds. Leiden, ESCOM, 1992, p. 88-90
5. Zimmerman AE, Moule ML, Yip CC: Guinea pig insulin II: biological activity. J Biol Chem 249:4026-4029, 1974
6. B25] -insulins. Biochem Biophys Res Commun 100:1229-1236, 1981
7. Hartmann H, Oberhaus K, Spahr R, Brandenburg D, Creutzfeldt W, Probst I: Biological activity of des-(B26-B30)-insulinamide and related analogues in rat hepatocyte cultures. Diabetologia 32:416-420, 1989
8. Brange J, Owens DR, Kang S, Voølund A Monomeric insulins and their experimental and clinical implications. Diabetes Care 13:923-954, 1990
9. Zeuzem S, Stahl E, Jungmann E, Zoltobrocki M, Schöffling K, Caspary WF: In vitro activity of biosynthetic human diarginylinsulin. Diabetologia 33:65-71, 1990
10. Robertson DA, Singh BM, Hale PJ, Jensen I, Nattrass M: Metabolic effects of monomeric insulin analogues of different receptor affinity. Diabetic Med 9:240-246, 1992
11. Peavy DE, Abram JD, Frank BH, Duckworth WC: In vitro activity of biosynthetic human proinsulin: receptor binding and biologic potency of proinsulin and insulin in isolated rat adipocytes. Diabetes 33:1062-1067, 1984
12. Podlecki DA, Frank BH, Olefsky JM: In vitro characterization of biosynthetic human proinsulin. Diabetes 33:111-118, 1984
13. Peavy DE, Brunner MR, Duckworth WC, Hooker CS, Frank BH: Receptor binding and biological potency of several split forms (conversion intermediates) of human proinsulin: studies in cultured IM-9 lymphocytes and in vivo and in vitro in rats. J Biol Chem 260:13989-13994, 1985
14. Schwarte GP, Burke GT, Katsoyannis PG: A superactive insulin: [B10-aspartic acid]insulin (human). Proc Natl Acad Sci USA 84:6408-6411, 1987
15. Burke GT, Hu SQ, Ohta N, Schwartz GP, Zong L, Katsoyannis PG: Superactive insulins. Biochem Biophys Res Commun 173:982-987, 1990
16. Chap Z, Ishida T, Chou J, Hartley CJ, Entman ML, Brandenburg D, Jones RH, Field JB: First-pass hepatic extraction and metabolic effets of insulin and insulin analogues. Am J Physiol 252 (Endocrinol Metab 15):E209-E217, 1987
17. Sodoyez-Goffaux F, Sodoyez J-C, Koch M, De Vos CJ, Frank BH: Scintigraphic distribution of 123 I labelled proinsulin, split conversion intermediates and insulin in rats. Diabetologia 31:848-854, 1988
18. Jensen I, Kruse V, Larsen UD: Scintigraphic studies in rats: kinetics of insulin analogues covering wide range of receptor affinities. Diabetes 40:628-632, 1991
19. 29-lysine. Diabetologia 12:601-608, 1976
20. Ribel U, Hougaard P, Drejer K, Sørensen AR: Equivalent in vivo biological activity of insulin analogues and human insulin despite different in vitro potencies. Diabetes 39:1033-1039, 1990
21. Mosekilde E, Jensen KS, Binder C, Pramming S, Thorsteinsson B: Modeling absorption kinetics of subcutaneous injected soluble insulin. J Pharma-cokinet Biopharm 17:67-87, 1989
22. 13C labeling with application to protein design. Biochemistry 30:7373-7389, 1991
23. Shoelson SE, Lu Z-X, Parlautan L, Lynch CS, Weiss MA: Mutations at the dimer, hexamer, and receptor-binding surfaces of insulin independently affect insulin-insulin and insulin-receptor interactions. Biochemistry 31:1757-1767, 1992
24. Slieker LJ, Brooke GS, Chance RE, Fan L, Hoffmann JA, Howey DC, Long HB, Mayer J, Shields JE, Sundell KL, DiMarchi RD: Insulin and IGF-I analogs: novel approaches to improved insulin pharmacokinetics. In Current Directions in Insulin-Like Growth Factor Research. LeRoith D, Raizada MK, Eds. New York, Plenum Press, 1994, p. 25-32
25. Brems DN, Alter LA, Beckage MJ, Chance RE, DiMarchi RD, Green LK, Long, HB, Pekar AH, Shields JE, Frank BH: Altering the association properties of insulin by amino acid replacement. Protein Engineering 5:527-533, 1992
26. B29-insulin: dissociation of a protein-ligand complex. Protein Sci 5:2521-2531, 1996
27. Chance RE, Hoffmann JA, Kroeff EP, Johnson MG, Schirmer EW, Bromer WW, Ross MJ, Wetzel R: The production of human insulin using recombinant DNA technology and a new chain combination procedure. In Peptides: Synthesis, Structure and Function; Proceedings of the Seventh American Peptide Symposium. Rich DH, Gross E, Eds. Rockford, Pierce Chemical Co., 1981, p.721-728
28. Robbins DC, Andersen L, Bowsher R, Chance R, Dinesen B, Frank B, Gingerich R, Goldstein D, Widemeyer H-M, Haffner S, Hales CN, Jarett L, Polonsky K, Porte D, Skyler J, Webb G, Gallagher K: Report of the American Diabetes Association's task force on standardization of the insulin assay. Diabetes 45:242-256, 1996
29. Herbert V, Lau K-S, Gottlieb CW, Bleicher SJ: Coated charcoal immunoassay of insulin. J Clin Endocrinol Metab 25:1375-1384, 1965
30. Radziuk J, Norwich KH, Vranic M: Experimental validation of measurements of glucose turnover in nonsteady state. Am J Physiol 234:E84-E93, 1978
31. Morishima T, Pye S, Polonsky K, Radziuk J: The measurement and validation of nonsteady-state rates of C-peptide appearance in the dog. Diabetologia 29:440-446, 1986
32. Radziuk J, Morishima T: Assessment of insulin kinetics in vivo. In Methods in Diabetes Research, Vol. II: Clinical Methods. Lamer J, Ed. New York, Academic Press, 1986, p. 91-106
33. Radziuk J: Mathematical basis for the measurement of the rates of glucose appearance and synthesis in vivo. In Methods in Diabetes Research, Vol. II: Clinical Methods. Lamer J, Ed. New York, Academic Press, 1986, p. 143-164
34. Gabriel KR: The model of ante-dependence for data of biological growth. Bull Inst Int Stat 39:253-264, 1962
35. B29-human insulin. Structure 3:615-622, 1995.
36. Radziuk J, Norwich KH, Vranic M: Measurement and validation of non-steady turnover rates with application to the insulin and glucose systems. Fed Proc 33:1855-1864, 1974
37. Sherwin RS, Kramer KJ, Tobin JD, Insel PA, Liljenquist JE, Berman M, Andres R: A model of the kinetics of insulin in man. J Clin Invest 53: 1481-1492, 1974
38. Bergman RN, Ider YZ, Bowden CR, Cobelli C: Quantitative estimation of insulin sensitivity. Am J Physiol 236:E667-E677, 1979
39. Glauber HS, Revers RR, Henry R, Schmeiser L, Wallace P, Kolterman OG, Cohen RM, Rubenstein AH, Galloway JA, Frank BH, Olefsky JM: In vivo deactivation of proinsulin action on glucose disposal and hepatic glucose production in normal man. Diabetes 35:311-317, 1986
40. Deckert T, Hansen B, Koølendorf K, Dirch-Poulsen JS, Smith M: Absorption of NPH-insulin from subcutaneous tissue: a methodological study in pigs. Acta Pharmacol Toxicol 51:30-37, 1982
41. B28) on meal-related plasma glucose excursions in type I diabetic subjects. Diabetes Care 14:571-577, 1991
42. Heinemann L, Starke AAE, Heding L, Jensen I, Berger M: Action profiles of fast onset insulin analogues. Diabetologia 33:384-386, 1990
43. Bartek MJ, LaBudde JA, Maibach HI: Skin permeability in vivo: comparison in rat, rabbit, pig, and man. J Invest Dermatol 58:114-123, 1972
44. Meyer W, Schwarz R, Neurand K: The skin of domestic mammals as a model for the human skin, with special reference to the domestic pig. Curr Probl Dermatol 7:39-52, 1978
45. Morishima T, Bradshaw C, Radziuk J: Measurement using tracers of steady-state turnover and metabolic clearance of insulin in dogs. Am J Physiol 248 (Endocrinol Metab 11):E203-E208, 1985
46. Morishima T, Pye S, Bradshaw C, Radziuk J: Posthepatic rate of appearance of insulin: measurement and validation in the nonsteady state. Am J Physiol 263 (Endocrinol Metab 26):E772-E779, 1992
47. Finegood DT, Bergman RN, Vranic M: Estimation of endogenous glucose production during hyperinsulinemic-euglycemic glucose clamps: comparison of unlabeled and labeled exogenous glucose infusates. Diabetes 36:914-924, 1987
48. Alzaid AA, Dinmeen SF, Turk DJ, Caumo A, Cobelli C, Rizza RA: Assessment of Insulin action and glucose effectiveness in diabetic and nondiabetic humans. J Clin Invest 94:2341-2348,1994
49. Cobelli C, Man A, Ferrannini E: Non-steady state: error analysis of Steele's model and developments for glucose kinetics. Am J Physiol 252:E679-E689, 1987
50. Howey DC, Bowsher RR, Brunelle RL, Woodworth JR: [Lys(B28), Pro(B29)]-human insulin: a rapidly absorbed analogue of human insulin. Diabetes 43:396-402, 1994
51. Howey DC, Bowsher RR, Brunelle RL, Rowe HM, Santa PF, Downing-Shelton J, Woodworth JR: (Lys(B28), Pro(B29)]-human insulin: effect of injection time on postprandial glycemia. Clin Pharmacol Ther 58:459-469, 1995
52. Garg SK, Carmain JA, Braddy KC, Anderson JH, Vignati L, Jennings MK, Chase HP: Pre-meal insulin analogue insulin Lispro vs Humulin®R insulin treatment in young subjects with type 1 diabetes. Diabetic Med 13:47-52, 1996